The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Analytics · HPLC & UHPLC

Revisiting: Why I ask for the gradient before I discuss the number

DN
d.nwosuTL23 Mar 2025#1

Posting this under the heading it deserves: Revisiting: Why I ask for the gradient before I discuss the number Everything below is what sits behind that.

I would like to understand what this number means before I repeat it anywhere.

A Medutest report on a tirzepatide lot gives 98.4% purity. The supplier certificate for the same lot states 98.2%. Both documents name a reversed-phase method; neither states the same gradient.

My question is not "who is right". It is: given that those two figures were produced by different methods, what is the largest difference I should expect from method alone, and at what point does a gap stop being explainable that way?

7 likes 17mo
ID
il.dumitruTL224 Mar 2025 · edited#2

Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher efficiency than larger particles (3.5 μm or 5 μm), at the cost of higher back pressure. Newer methods increasingly use smaller particles.

11 likes 16mo
GH
g.haalandTL3Regular8 Apr 2025#3

Picking up the opening post: that is the part I would want checked first.

Gradient delay volume differs between instruments and shifts the whole chromatogram. It is why a transferred method rarely reproduces retention times exactly on a different system.

33 likes 16mo
EC
e.coelhoTL221 Apr 2025#4

Clear enough that I do not think I have a follow-up, which is unusual.

0 likes 15mo
FA
f.abrahamsenTL2Member4 May 2025#5
d.nwosu, post #1: Posting this under the heading it deserves: Revisiting: Why I ask for the gradient before I discuss the number Everything below is what sits behind that. I would like to understand what this number means before I repeat it anywhere. A Medutest report on a tirzepatide lot gives 98.4% purity. The supplier certificate for the same lot… Go to post

Purity by chromatography answers "what proportion of what I detected is the intended species". It does not answer how much is in the vial, which is a separate assay.

Marking that as an opinion rather than a finding.

1 like in reply to #1 15mo
CH
ca.haddadTL216 May 2025#6

Where the baseline is drawn is the least documented and most consequential choice in the whole determination. Valley-to-valley, tangent skim and forced-to-zero can span a couple of percentage points on the same chromatogram.

That is what the documentation says. What happens in practice is usually close.

7 likes 14mo
G
GDashwoodTL3Regular27 May 2025#7

System suitability testing: injections run before and during the sample run to establish whether the instrument, column and method were performing when the sample was analysed. If suitability did not pass, the sample results from that run are uninterpretable.

A single observation, in a thread that deserves better than single observations.

24 likes 14mo
MY
m.yilmazTL27 Jun 2025#8
GI
g.ibarraTL217 Jun 2025#9

Narrowing post #7, because the general version has more than one answer.

Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction coefficient. For closely related impurities the approximation is usually good. For structurally dissimilar impurities it can be poor.

11 likes 13mo
SC
s.cardosoTL228 Jun 2025#10

Everything in post #6 holds. The case it does not cover is the one I have.

Change the wavelength and the proportions change even though the sample has not. That is the reason the wavelength has to be on the document for the number to mean anything.

I would be glad to be shown a cleaner way of putting this.

23 likes 13mo
AW
am.wikstromTL28 Jul 2025#11

Worth separating two things that post #9 runs together.

Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run resolves more impurities and gives a higher purity figure. A steep gradient produces a tidier-looking chromatogram with fewer visible peaks and gives a lower purity figure. Both are legitimate methods and they will not produce the same number.

That much is documented. The rest is how I have interpreted it.

8 likes 13mo
I
IbrahimoviTL2Member17 Jul 2025#12

Fair, and the limits you put on it are the part I will remember.

2 likes 12mo
ZN
z.nakamuraTL227 Jul 2025#13
il.dumitru, post #2: Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher efficiency than larger particles (3.5 μm or 5 μm), at the cost of higher back pressure. Newer methods increasingly use smaller particles. Go to post

Trifluoroacetic acid at 0.1 per cent is the near-universal ion-pairing additive for this work, and it also raises the baseline at 214 nanometres. That is why the same sample looks noisier at low wavelength.

It is the kind of thing that is obvious once and never again.

0 likes in reply to #2 12mo
D
DSakamotoTL3Regular5 Aug 2025#14

Post #13 answers the question as asked. The question underneath it is different.

Peaks that do not elute do not appear in the area percentage. Aggregates and strongly retained species can be entirely invisible to a standard method, which is a ceiling on what any purity figure can claim.

I would put a moderate confidence on that and no more.

26 likes 12mo
TL
t.lindqvistTL215 Aug 2025 · edited#15

Post #13 and I disagree about the size of the effect, not about the direction.

Column temperature affects retention and selectivity and is omitted from most certificates. Two runs at twenty-five and forty degrees are not the same method.

That is all the detail I have. Someone else will have more.

5 likes 11mo
M
MSaarinenTL3Regular24 Aug 2025#16

Taking post #13 at face value and following it one step further.

A shallow gradient resolves close-eluting species that a steep one merges. Two honest laboratories running different gradients can report genuinely different purities on the same vial.

That is the honest state of it as of this week.

0 likes 11mo
BB
b.brandtTL22 Sep 2025#17
d.nwosu, post #1: Posting this under the heading it deserves: Revisiting: Why I ask for the gradient before I discuss the number Everything below is what sits behind that. I would like to understand what this number means before I repeat it anywhere. A Medutest report on a tirzepatide lot gives 98.4% purity. The supplier certificate for the same lot… Go to post

A chromatogram image at a resolution where you can see peak shape but not baseline detail is worth having and is not the same as the data. Ask for the integration table if the number matters.

0 likes in reply to #1 11mo
CN
cannula_notesTL2Member10 Sep 2025#18
DSakamoto, post #14: Post #13 answers the question as asked. The question underneath it is different. Peaks that do not elute do not appear in the area percentage. Aggregates and strongly retained species can be entirely invisible to a standard method, which is a ceiling on what any purity figure can claim. I would put a moderate confidence on that and no… Go to post

If two laboratories disagree by more than two or three percentage points, work through method, integration, sample handling, whether it was the same lot and the same vial, and whether suitability passed. After all five, a gap needs an explanation.

Anyone with a larger sample, please post it.

19 likes in reply to #14 11mo
MM
m.malinowskiTL219 Sep 2025#19

Good question, well framed, and I would like to see it answered properly.

2 likes 10mo
AW
a.westergaardTL3Regular28 Sep 2025#20

Adding the measurement that post #17 says would settle it.

This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why two competent laboratories can report different numbers on the same vial without either being wrong.

I would put the burden of proof on the interesting explanation, not the dull one.

0 likes 10mo

Suggested topics

TopicParticipantsRepliesViewsActivity
[2026 update] Area percent versus weight percent: the confusion that causes most arguments
On the subject in the title: Area percent versus weight percent: the confusion that causes most arguments Working notes rather than a conclusion. Proposing that Area percent versus weight percent deserves a…
BIISCJBSG+65 70 1.1k 16d
Shoulders, tangent skims, and defensible integration — the long version
Shoulders, tangent skims, and defensible integration — the long version Writing it up because I had to work it out twice and would rather nobody else did. Setting out an integration problem with the actual…
VSCBAWSLEL+16 20 27k 3mo
Detection wavelength and why 214 nm and 280 nm disagree
On the subject in the title: Detection wavelength and why 214 nm and 280 nm disagree Working notes rather than a conclusion. I would like to disagree carefully with the settled view on detection wavelength,…
BWZVGFFEDI+78 84 1.7k 8mo
Coming back to: Column chemistry choices for a 40-residue peptide
On the subject in the title: Column chemistry choices for a 40-residue peptide Working notes rather than a conclusion. Column chemistry choices — I have the observation and I do not trust my interpretation of…
MLFPHB 2 43k 16mo
Injection volume, overload, and peak distortion — one year on
Injection volume, overload, and peak distortion — one year on Writing it up because I had to work it out twice and would rather nobody else did. Posting a small dataset on Injection volume. It is mine, it is…
DTCNFEGFZV+4 8 1.2k 4mo

Related topics — sharing the tags UV & DAD detection, data table, peak integration

TopicParticipantsRepliesViewsActivity
Revisiting: Sample handling between despatch and injection
Posting this under the heading it deserves: Revisiting: Sample handling between despatch and injection Everything below is what sits behind that. Reading back through what has been written here about Sample…
DVEAGTEMNG+5 9 1.1k 6mo
Designing a personal experiment that could change your mind
Posting this under the heading it deserves: Designing a personal experiment that could change your mind Everything below is what sits behind that. I was wrong about designing a personal experiment in a thread…
MGECFACHG+2 6 695 6mo
Comparing my trajectory with the trial curves, carefully
Posting this under the heading it deserves: Comparing my trajectory with the trial curves, carefully Everything below is what sits behind that. Maintenance rather than loss, which is the part of this that…
PGFCVWZV+86 92 54k 7mo
Whether an aggregate is worth publishing at all: a disputed topic — does this still hold?
Whether an aggregate is worth publishing at all: a disputed topic — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. An honest uncertainty about…
BDHFBWIBOF+14 18 3.4k 2mo
An ABAB design with a data table and honest limitations — a second dataset
On the subject in the title: An ABAB design with a data table and honest limitations — a second dataset Working notes rather than a conclusion. Posting a small dataset on ABAB design. It is mine, it is…
VELIGRAC+106 118 25k 4mo